{ "cik": 1819790, "cik_padded": "0001819790", "entityName": "Tarsus Pharmaceuticals, Inc.", "fiscal_years": [ { "accn": "0001819790-26-000019", "filed": "2026-02-23", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9859000.0, "cash": 183640000.0, "eps_diluted": -1.59, "free_cash_flow": -22310000.0, "net_income": -66418000.0, "operating_cash_flow": -12451000.0, "operating_income": -70969000.0, "revenue": 451360000.0, "stockholders_equity": 343426000.0, "total_assets": 562158000.0, "total_liabilities": 218732000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6369115908521777, "net_margin": -0.1471508330379298, "operating_margin": -0.1572336937256292, "revenue_growth_yoy": 1.4670817095100928, "roa_avg2y": -0.14144294462327064, "roa_period_end": -0.11814827859783193, "roe_avg2y": -0.23388266779350658, "roe_period_end": -0.19339828667602338 } }, { "accn": "0001819790-26-000019", "filed": "2026-02-23", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1567000.0, "cash": 94818000.0, "eps_diluted": -3.07, "free_cash_flow": -84594000.0, "net_income": -115554000.0, "operating_cash_flow": -83027000.0, "operating_income": -120569000.0, "revenue": 182953000.0, "stockholders_equity": 224534000.0, "total_assets": 376991000.0, "total_liabilities": 152457000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.67899293648178, "net_margin": -0.6316048384011194, "operating_margin": -0.659016250075156, "revenue_growth_yoy": 9.486215395196883, "roa_avg2y": -0.3597112448286489, "roa_period_end": -0.3065166011920709, "roe_avg2y": -0.5482703156656118, "roe_period_end": -0.5146392083158898 } }, { "accn": "0001819790-26-000019", "filed": "2026-02-23", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1502000.0, "cash": 224947000.0, "eps_diluted": -4.62, "free_cash_flow": -118995000.0, "net_income": -135893000.0, "operating_cash_flow": -117493000.0, "operating_income": -143158000.0, "revenue": 17447000.0, "stockholders_equity": 196988000.0, "total_assets": 265491000.0, "total_liabilities": 68503000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3477521473389242, "revenue_growth_yoy": -0.32417880384257824, "roa_avg2y": -0.5508944895551673, "roa_period_end": -0.5118553924615147, "roe_avg2y": -0.6970873686802364, "roe_period_end": -0.6898542043170143 } }, { "accn": "0001819790-26-000019", "filed": "2026-02-23", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 506000.0, "cash": 71660000.0, "eps_diluted": -2.52, "free_cash_flow": -49536000.0, "net_income": -62091000.0, "operating_cash_flow": -49030000.0, "operating_income": -62712000.0, "revenue": 25816000.0, "stockholders_equity": 192900000.0, "total_assets": 227863000.0, "total_liabilities": 34963000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.18124935199585276, "revenue_growth_yoy": -0.5473021551195048, "roa_avg2y": -0.305288000590014, "roa_period_end": -0.27249268200629323, "roe_avg2y": -0.34530489669938547, "roe_period_end": -0.3218818040435459 } }, { "accn": "0001819790-25-000011", "filed": "2025-02-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 586000.0, "cash": 171332000.0, "eps_diluted": -0.67, "free_cash_flow": 3162000.0, "net_income": -13827000.0, "operating_cash_flow": 3748000.0, "operating_income": -12157000.0, "revenue": 57027000.0, "stockholders_equity": 166730000.0, "total_assets": 178907000.0, "total_liabilities": 12177000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07303424698614526, "net_margin": -0.24246409595454785, "operating_margin": -0.2131797218861241, "roa_avg2y": -0.07881349411050532, "roa_period_end": -0.07728596421604521, "roe_avg2y": -0.08311742959333955, "roe_period_end": -0.08293048641516224 } }, { "accn": "0001819790-23-000007", "filed": "2023-03-17", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 456000.0, "cash": 168129000.0, "eps_diluted": -4.32, "free_cash_flow": -21594000.0, "net_income": -26811000.0, "operating_cash_flow": -21138000.0, "operating_income": -26998000.0, "stockholders_equity": 165980000.0, "total_assets": 171972000.0, "total_liabilities": 5992000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.03610073502831666, "roa_avg2y": -0.23284756478843882, "roa_period_end": -0.15590328658153652, "roe_avg2y": -0.3351898734177215, "roe_period_end": -0.16153150982046027 } }, { "accn": "0001819790-22-000010", "filed": "2022-03-14", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 175000.0, "cash": 57952000.0, "free_cash_flow": -3848000.0, "net_income": -4670000.0, "operating_cash_flow": -3673000.0, "operating_income": -4298000.0, "stockholders_equity": -6005000.0, "total_assets": 58316000.0, "total_liabilities": 919000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -0.08008093833596269, "roe_avg2y": 1.2691941839923904 } }, { "accn": "0001819790-21-000010", "filed": "2021-03-31", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "net_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "net_income": -1319000.0, "stockholders_equity": -1354000.0 }, "period_end": "2018-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": 1.8869814020028612 } }, { "accn": "0001819790-21-000010", "filed": "2021-03-31", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -44000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001819790-26-000019", "filed": "2026-02-23", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001819790.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001819790.json" }, "ticker": "TARS" }